Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. | Director | Common Stock | 16.4K | $1.05M | $63.69 | Jan 1, 2024 | Direct |
Apellis Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 5.75K | $381K | $66.30 | Jan 1, 2024 | Direct |
GELESIS HOLDINGS, INC. | Director | Common Stock | 53.8K | May 6, 2022 | Direct | ||
Amylyx Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 25K | Jun 6, 2024 | Direct | ||
COVETRUS, INC. | Director | Common Stock | 0 | $20.88 | Oct 13, 2022 | Direct | |
COVETRUS, INC. | Director | Restricted Stock Units | 0 | Oct 13, 2022 | Direct |